Alopecia Areata: a New Treatment Plan

Overview

Journal Clin Cosmet Investig Dermatol

Publisher Dove Medical Press

Specialty Dermatology

Date 2011 Aug 12

PMID 21833161

Citations 21

Authors

Adel Alsantali

Affiliations

Soon will be listed here.

Abstract

Many therapeutic modalities have been used to treat alopecia areata, with variable efficacy and safety profiles. Unfortunately, none of these agents is curative or preventive. Also, many of these therapeutic agents have not been subjected to randomized, controlled trials, and, except for topical immunotherapy, there are few published studies on long-term outcomes. The treatment plan is designed according to the patient's age and extent of disease. In this paper, the therapeutic agents are organized according to their efficacy and safety profiles into first-line, second-line, and third-line options.

Citing Articles

"Hair is your crown and glory" - Black women's experiences of living with alopecia and the role of social support.

Clarke-Jeffers P, Keyte R, Connabeer K Health Psychol Rep. 2024; 12(2):154-165.

PMID: 38628276 PMC: 11016946. DOI: 10.5114/hpr/177730.

A diagnostic clue: New onset alopecia sparing white hairs.

Chen M, Liddell L, Brodell R JAAD Case Rep. 2024; 44:107-109.

PMID: 38362122 PMC: 10867332. DOI: 10.1016/j.jdcr.2023.11.030.

The Efficacy and Adverse Effects of Corticosteroid Pulse Therapy in Alopecia Areata: A Review Article.

Rastaghi F, Kaveh R, Yazdanpanah N, Sahaf A, Ahramyanpour N Dermatol Pract Concept. 2023; 13(4).

PMID: 37992355 PMC: 10656135. DOI: 10.5826/dpc.1304a255.

Treatments for alopecia areata: a network meta-analysis.

Mateos-Haro M, Novoa-Candia M, Sanchez Vanegas G, Correa-Perez A, Gaetano Gil A, Fernandez-Garcia S Cochrane Database Syst Rev. 2023; 10:CD013719.

PMID: 37870096 PMC: 10591288. DOI: 10.1002/14651858.CD013719.pub2.

Survey of pediatric dermatologist views on treatment for alopecia areata.

Bitterman D, Bitterman D, Sink J, Harfmann K, Hogeling M, Lauren C JAAD Int. 2023; 13:71-73.

PMID: 37711340 PMC: 10498288. DOI: 10.1016/j.jdin.2023.06.016.

References

DOvidio R, CLAUDATUS J, Di Prima T . Ineffectiveness of imiquimod therapy for Alopecia Totalis/Universalis. J Eur Acad Dermatol Venereol. 2002; 16(4):416-7. DOI: 10.1046/j.1468-3083.2002.00570_4.x. View

Nasiri S, Haghpanah V, Taheri E, Heshmat R, Larijani B, Saeedi M . Hair regrowth with topical triiodothyronine ointment in patients with alopecia areata: a double-blind, randomized pilot clinical trial of efficacy. J Eur Acad Dermatol Venereol. 2011; 26(5):654-6. DOI: 10.1111/j.1468-3083.2011.04088.x. View

Tosti A, Pazzaglia M, Voudouris S, Tosti G . Hypertrichosis of the eyelashes caused by bimatoprost. J Am Acad Dermatol. 2004; 51(5 Suppl):S149-50. DOI: 10.1016/j.jaad.2004.05.002. View

Buys C . Evaluation of anthralin in the treatment of alopecia areata. Arch Dermatol. 1987; 123(11):1491-3. View

. Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata. J Am Acad Dermatol. 1987; 16(3 Pt 2):745-8. DOI: 10.1016/s0190-9622(87)80003-8. View

Aghaei S . An uncontrolled, open label study of sulfasalazine in severe alopecia areata. Indian J Dermatol Venereol Leprol. 2009; 74(6):611-3. DOI: 10.4103/0378-6323.45103. View

FRIEDLI A, Labarthe M, Engelhardt E, Feldmann R, Salomon D, Saurat J . Pulse methylprednisolone therapy for severe alopecia areata: an open prospective study of 45 patients. J Am Acad Dermatol. 1998; 39(4 Pt 1):597-602. DOI: 10.1016/s0190-9622(98)70009-x. View

Phillips M, Graves J, Nunley J . Alopecia areata presenting in 2 kidney-pancreas transplant recipients taking cyclosporine. J Am Acad Dermatol. 2005; 53(5 Suppl 1):S252-5. DOI: 10.1016/j.jaad.2005.03.005. View

Broniarczyk-Dyla G, Wawrzycka-Kaflik A, Dubla-Berner M, Prusinska-Bratos M . Effects of psoralen-UV-A-Turban in alopecia areata. Skinmed. 2006; 5(2):64-8. DOI: 10.1111/j.1540-9740.2006.04240.x. View

10.

Nakajima T, Inui S, Itami S . Pulse corticosteroid therapy for alopecia areata: study of 139 patients. Dermatology. 2007; 215(4):320-4. DOI: 10.1159/000107626. View

11.

Strober B, Siu K, F Alexis A, Kim G, Washenik K, Sinha A . Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study. J Am Acad Dermatol. 2005; 52(6):1082-4. DOI: 10.1016/j.jaad.2005.03.039. View

12.

Ross E, Bolduc C, Lui H, Shapiro J . Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata. J Am Acad Dermatol. 2005; 53(6):1095-6. DOI: 10.1016/j.jaad.2005.06.031. View

13.

Lee D, Hong S, Park S, Hur D, Shon J, Shin J . Serum levels of IL-18 and sIL-2R in patients with alopecia areata receiving combined therapy with oral cyclosporine and steroids. Exp Dermatol. 2009; 19(2):145-7. DOI: 10.1111/j.1600-0625.2009.00937.x. View

14.

Orecchia G, Perfetti L . Alopecia areata and topical sensitizers: allergic response is necessary but irritation is not. Br J Dermatol. 1991; 124(5):509. DOI: 10.1111/j.1365-2133.1991.tb00643.x. View

15.

Al-Mutairi N . 308-nm excimer laser for the treatment of alopecia areata in children. Pediatr Dermatol. 2009; 26(5):547-50. DOI: 10.1111/j.1525-1470.2009.00980.x. View

16.

Wilkerson M, Henkin J, Wilkin J . Diphenylcyclopropenone: examination for potential contaminants, mechanisms of sensitization, and photochemical stability. J Am Acad Dermatol. 1984; 11(5 Pt 1):802-7. DOI: 10.1016/s0190-9622(84)80456-9. View

17.

Sasmaz S, Arican O . Comparison of azelaic acid and anthralin for the therapy of patchy alopecia areata: a pilot study. Am J Clin Dermatol. 2005; 6(6):403-6. DOI: 10.2165/00128071-200506060-00007. View

18.

Yoo K, Lee J, Li K, Kim B, Kim M . Photodynamic therapy with methyl 5-aminolevulinate acid might be ineffective in recalcitrant alopecia totalis regardless of using a microneedle roller to increase skin penetration. Dermatol Surg. 2010; 36(5):618-22. DOI: 10.1111/j.1524-4725.2010.01515.x. View

19.

Dyall-Smith D . Alopecia areata in a renal transplant recipient on cyclosporin. Australas J Dermatol. 1996; 37(4):226-7. DOI: 10.1111/j.1440-0960.1996.tb01066.x. View

20.

Sternthal M, Murphy S, George J, Kornbluth A, Lichtiger S, Present D . Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease. Am J Gastroenterol. 2008; 103(4):937-43. DOI: 10.1111/j.1572-0241.2007.01718.x. View